Earnings Reported After The Bell Nov.10

(RTTNews) - Here is a quick summary of the earnings reported after the bell on Nov. 10.

Arena Pharmaceuticals, Inc. (ARNA)

Q3 Net loss was $26.4 million, or $0.11 per share vs. net loss of $10.67 million or $0.05 per share a year ago.

Revenues totaled $9.14 million vs. $8.16 million a year ago.

***

Invuity, Inc. (IVTY)

Q3 net loss was $9.1 million, or $0.69 per share, compared to net loss of $5.3 million, or $8.11 per share a year ago.

Revenue grew 50% to $5.6 million compared to $3.7 million a year ago.

***

China Lodging Group Limited (HTHT)

Q3 net income totaled RMB223.65 million, or RMB0.87 per share vs. RMB149.60 million, or RMB0.59 per share, in last year's third quarter.

Revenue for the quarter rose 15.1% to RMB1.60 billion from RMB1.39 billion last year.

***

UQM TECHNOLOGIES, INC. (UQM)

Q2 Net loss was $2.4 million, or $0.06 per share vs. net loss of $2.0 million, or $0.05 per share for the same period last year.

Total revenue for the quarter was $1.7 million, a 55% increase compared with $1.1 million in the same quarter last year.

***

Opexa Therapeutics, Inc. (OPXA)

Q3 Net loss was $2.8 million, or $0.42 per share compared with net loss of $3.9 million, or $1.11 per share a year ago.

Revenue was $726,291 vs.$307,686 a year ago.

***

Kinross Gold Corporation (KGC)

Q3 net loss was $52.7 million, or $0.05 per share compared with net loss of $4.3 million, or $0.00 per share a year ago.

Adjusted loss was $23.9 million, or $0.02 per share, compared with adjusted earnings of $70.1 million, or $0.06 per share a year ago.

Revenue was $809.4 million, compared with $945.7 million a year ago.

***

WaferGen Bio-systems, Inc. (WGBS)

Q3 Net loss was $3.5 million, or $0.61 per share, compared to net loss of $2.8 million, or $1.02 per share a year ago.

Total revenue was $2.0 million compared to $1.3 million for the prior year period.

FY Outlook

Revenue to be between $7.8 million and $8.2 million.

***

Ideal Power Inc. (IPWR)

Q3 net loss was $2.9 million or $0.31 per share compared to $1.9 million or $0.26 per share in the comparable prior year period.

Product revenue increased 210% to $0.9 million from $0.3 million a year ago.

***

Amdocs Ltd (DOX)

Q4 net income was $130.35 million, or $0.84 per share from $124.27 million, or $0.78 per share, in last year's fourth quarter.

Revenue for the quarter rose 2.9% to $926.78 million from $900.26 million last year.

Analysts expected the company to report net income of $0.82 per share on revenues of $932.36 million for the period.

Q1 Outlook

EPS to be in the range of $0.82 - $0.88

Revenue to be in the range of $905 million - $945 million.

Analysts expect the company to report net income of $0.90 per share on revenues of $953.39 million for the period.

***

Transition Therapeutics Inc. (TTHI)

Q1 net loss was $4.49 million or $0.12 per share compared to net loss of $15.7 million or $0.45 per share a year ago.

***

Navigator Holdings Ltd. (NVGS)

Q3 Net income was $22.67 million or $0.41 per share vs. $23.66 million or $0.43 per share a year ago.

Operating revenue was $78.22 million vs. $80.61 million a year ago.

Analysts expected the company to report net income of $0.45 per share on revenues of $72.94 million for the period.

***

Everyday Health, Inc. (EVDY)

Q3 Net loss was $12.7 million, compared to net loss of $0.1 million in the prior year period.

Loss per share was $0.40 compared to $0.00 a year ago.

Non-GAAP net income was $2.3 million, compared to $2.9 million in the prior year period.

Non-GAAP earnings per share was $0.07, compared to $0.09 a year ago.

Total revenue was $54.3 million vs. $42.32 million a year ago.

Analysts expected the company to report net income of $0.08 per share on revenues of $56.83 million for the period.

Q4 Outlook

Total revenue to be in the range of$75.0 million- $80.0 million; Consensus $87.26 million.

***

Zafgen, Inc. (ZFGN)

Q3 net loss was $19.9 million, or $0.73 per share, compared to net loss of $14.7 million, or $0.65 per share a year ago.

***

Covisint Corporation (COVS)

Q2 net loss was $4.13 million or $0.10 per share vs. net loss of $7.3 million or $0.19 per share a year ago.

Non-GAAP loss per share was $0.09 compared to loss per share of $0.13in the same quarter last year.

Revenue was $18.39 million vs. $21.74 million a year ago.

***

Glaukos Corporation (GKOS)

Q3 net loss attributable to Glaukos shareholders was $2.1 million, or $0.07 per share compared to $1.5 million, or $0.64 per share, in the same period one year ago.

Net sales rose 57% to $19.0 million, compared to $12.1 million in the same period a year ago.

FY Outlook

The company expects full-year net sales to be in the range of $70.5 million to $71.5 million.

***

Tobira Therapeutics, Inc. (TBRA)

Q3 net loss was $22.2 million, or $1.22 per share compared with net loss of $2.9 million, or $7.29 per share a year ago.

***

pdvWireless, Inc. (PDVW)

Q2 net loss was $5.46 million or $0.38 per share, compared with net loss of $3.02 million or $0.25 per share, the previous year.

Revenue for the quarter was $811,000 compared with $689,000 a year ago.

***

Juno Therapeutics, Inc. (JUNO)

Q3 net loss attributable to common stockholders was $23.2 million, or $0.26 per share, vs. net loss of $71.9 million, or $10.50 per share, a year ago.

Non-GAAP net loss attributable to common stockholders was $47.6 million, or $0.53 per share.

Revenue was $1.6 million vs. nil a year ago.

***

Iteris, Inc. (ITI)

Q2 net loss was $395,000 or $0.01 per share, compared to net loss of $187,000 or $0.01 per share in the year-ago quarter.

Non-GAAP net loss in the second quarter was $356,000 or $0.01 per share, compared to net income of $588,000 or $0.02 per share in the same quarter a year ago.

Total revenues in the second quarter increased to $20.6 million compared to $18.6 million in the same quarter a year ago.

***

ImmunoCellular Therapeutics, Ltd. (IMUC)

Q3 net loss was $3.4 million, or $0.04 per share, compared to net loss of $1.9 million, or $0.03 per share a year ago.

***

Full House Resorts (FLL)

Q3 net income was $2.0 million, or $0.11 per share, compared to net loss of $766,000, or $0.04 per share, in the prior-year period.

Net revenues in the third quarter were $34.3 million versus $32.9 million in the prior-year period.

Analysts expected the company to report net income of $0.07 per share on revenues of $32.65 million for the period.

***

Boot Barn Holdings, Inc. (BOOT)

Q2 net loss was $3.3 million, or $0.13 per share vs. net income of $0.9 million or $0.05 per share in the prior-year period.

Adjusted net income was $1.2 million, or $0.04 per share compared to $2.0 million or $0.08 per share in the prior-year period.

Net sales increased 50% to $129.7 million from $86.4 million in the second quarter of last year.

***

PRO-DEX, INC. (PDEX)

Q1 Loss from continuing operations was $125,000 or $0.03 per share compared to loss of $181,000 or $0.04 per share in the prior year's corresponding quarter.

Q1 net sales were $4.1 million vs. $2.6 million a year ago.

***

Westport Innovations Inc. (WPRT)

Q3 net loss was $37.4 million or $0.58 per share vs. net loss of $25.5 million or $0.40 per share a year ago.

Revenue was $22.3 million vs. $25.3 million a year ago.

***

Euroseas Ltd. (ESEA)

Q3 net loss attributable to common shareholders was $1.8 million or $0.29 per share vs. net loss of $4.1 million or $0.72 p0er share a year ago.

Adjusted net loss attributable to common shareholders was $0.26 per share vs. loss per share of $0.74 a year ago.

Net revenues were $11.3 million vs. $9.9 million a year ago.

***

Inogen, Inc. (INGN)

Q3 net income increased 26.4% to $2.7 million or $0.13 per share from $2.1 million or $0.11 per share in the third quarter of last year.

Total revenue rose 38.7% to $40.8 million, from $29.4 million a year ago.

FY Outlook

Inogen is increasing its 2015 revenue guidance to a range of $150 to $153 million vs. previous revenue expectation of $145 to $149 million.

FY2016 Outlook

Full year 2016 total revenue to be in the range of $177 million to $183 million

***

Alarm.com Holdings, Inc. (ALRM)

Q3 Net income attributable to common stockholders was $3.2 million or $0.07 per share, compared to $0.1 million, or $0.03 per share a year ago.

Adjusted net income attributable to common stockholders was $6.5 million or $0.14 per share, compared to $1.2 million, or $0.27 per share a year ago.

Total revenue increased 26% to $54.0 million for the third quarter compared to $42.8 million a year ago.

Analysts expected the company to report net income of $0.02 per share on revenues of $47.48 million for the period.

FY Outlook

Total revenue is now expected to be in the range of $197.7 million to $200.1 million, vs. previous guidance range of $193.9 million to $195.3 million

Adjusted net income attributable to common stockholders is now expected to be in the range of $0.20 to $0.21 per share compared to the previous guidance range of $0.13 to $0.14 per share.

Analysts expect the company to report net income of $0.14 per share on revenues of $194.68 million for the period.

***

A-Mark Precious Metals, Inc. (AMRK)

Q1 Net income increased 371% to $5.4 million or $0.76 per share from $1.1 million or $0.16 per share in the same year-ago quarter.

Revenues increased 38% to $2.01 billion from $1.45 billion in the same year-ago quarter

***

Aptose Biosciences Inc. (APTO)

Q3 Net loss was $3.3 million or $0.27 per share compared with net loss of $4.2 million or $0.36 per share during the four months ended September 30, 2014.

***

Metabolix, Inc. (MBLX)

Q3 net loss from continuing operations was $5.85 million, or $0.22 per share, as compared to net loss from continuing operations of $6.71 million or $0.71 per share a year ago.

Total revenue from continuing operations in the third quarter was $0.7 million, compared to $0.6 million a year ago.

***

Lumentum Holdings Inc. (LITE)

Q1 net loss was $0.4 million, or $0.01 per share vs. net loss of $15.8 million, or $0.27 per share a year ago.

Non-GAAP net income for the first quarter was $15.3 million or $0.26 per share vs. $8.9 million, or $0.15 per share a year ago.

Revenue was $212.6 million vs. $208.9 million a year ago.

Q2 Outlook

Net revenue to be in the range of $212 million to $222 million and non-GAAP earnings per share to be in the range of $0.26 to $0.30 per share.

***

Dicerna Pharmaceuticals, Inc. (DRNA)

Q3 Net loss attributable to common stockholders was $16.9 million or $0.82 per share compared to net loss of $11.2 million or $0.63 per share a year ago.

***

Resonant Inc. (RESN)

Q3 net loss was $2.87 million or $0.40 per share vs. net loss of $1.45 million or $0.21 per share a year ago.

***

Evolving Systems, Inc. (EVOL)

Q3 net income was $0.6 million, or $0.05 per share versus $1.7 million, or $0.14 per share in the same quarter last year.

Revenue was $5.8 million vs. $7.6 million a year ago.

Analysts expected the company to report net income of $0.07 per share on revenues of $6.26 million for the period.

***

Opower (OPWR)

Q3 GAAP net loss was $8.3 million, compared to $8.2 million a year ago.

GAAP net loss per share was $0.16 vs. net loss per share of $0.17 for the comparable period last year.

Non-GAAP net loss was $3.0 million, compared with $3.7 million a year ago.

Non-GAAP net loss per share was $0.06 vs. non-GAAP net loss per share of $0.08 for the comparable period last year.

Total revenue for the third quarter was $38.9 million, an increase of 15 percent from the comparable period a year ago.

Q4 Outlook

Revenue to be in the range of 39.6 million - 40.3 million.

GAAP net loss per share to be in the range of 0.29 - 0.27.

Non-GAAP net loss per share to be in the range of 0.15 - 0.13.

FY Outlook

Revenue to be in the range of 147.8 million -148.5 million.

GAAP net loss per share to be in the range of 0.90 - 0.88.

Non- GAAP net loss per share to be in the range of 0.44 -0.42.

***

51job Inc. (JOBS)

Q3 net income was RMB166.81 million, or RMB2.82 per share vs. RMB150.37 million, or RMB2.52 per share, in last year's third quarter.

Revenue for the quarter rose 10.8% to RMB524.98 million from RMB473.97 million last year.

Q4 Outlook

EPS to be in the range of RMB2.50 to RMB2.70

Revenue to be in the range of RMB580 million - RMB600 million.

***

Netlist, Inc. (NLST)

Q3 net loss was $5.4 million, or $0.11per share, compared to net loss in the prior year period of $4.1 million, or $0.10 per share.

Revenues were $1.6 million, compared to $4.8 million a year ago.

***

aTyr Pharma, Inc. (LIFE)

Q3 Net loss attributable to common stockholders was $11.33 million or $0.48 per share vs. net loss of $6.77 million or $8.02 per share a year ago.

***

OXiGENE, Inc. (OXGN)

Q3 net loss was $3.6 million or $0.14 per share compared to net loss of $3.5 million or $0.17 per share a year ago.

***

Ocular Therapeutix, Inc. (OCUL)

Q3 net loss was $11.5 million, or $0.47 per share compared to net loss of $7.3 million, or $0.48 per share a year ago.

Q3 revenue was $429000 vs. $143000 a year ago.

***